Compare — Georgia Financials

panel 2026-09-21Ask

Pooled trend

2 companies

Aggregate by year

GEL, thousands · money Σ · ratios from summed bases · growth on the pooled series

Metric	FY 2017	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024
Revenue	397,444	432,197	490,235	547,381	742,144	796,280	885,445	1,044,077
EBITDA	34,900	40,889	62,445	85,995	110,094	90,611	102,050	121,642
Net profit	24,860	30,469	21,777	30,437	86,802	66,980	61,881	73,649
Total assets	402,351	430,865	488,404	528,282	605,519	675,139	755,705	864,366
n (companies reporting)	2	2	2	2	2	2	2	2

Per-company contribution by year

XLSX

GEL, thousands

Company	FY 2017	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024
Aversi-Pharma	366,150	409,571	456,542	508,166	690,807	737,781	825,680	980,306
Aversi-Rational	31,294	22,626	33,693	39,215	51,337	58,499	59,765	63,771

Rows are the raw pool — every peer, including any excluded from the sums above, so the de-duplication stays auditable. Tinted cells are the excluded company-years.

Pooled figures sum every peer in the set. Known parent/subsidiary groups that file separately are de-duplicated; groups not yet curated may still be counted more than once.